Oura and Dexcom join forces to transform metabolic health
Longevity Technology - 21-Nov-2024Integrated glucose monitoring and wearable insights offer a personalized approach to health tracking
Investments News
TRexBio raises $84M to develop immune therapies targeting inflammation
Longevity Technology - 20-Nov-2024Funding strengthens their capacity to address unmet needs in immune-related diseases
Jupiter Bioventures: transforming early-stage science into biotech success
Endpoints News - 19-Nov-2024A $70m fund takes bold risks to validate ground-breaking ideas and reshape biotech innovation
Cytomos raises £5 million to expand innovative cell analysis
Business Insider - 19-Nov-2024Their technology reduces costs and accelerates drug development by six months
Theranautilus raises $1.2 million to develop nanorobots for dental hypersensitivity
The Economic Times - 19-Nov-2024The funding enables industrial production, clinical trials, and patent filing
OneSkin raises $20m to revolutionize anti-ageing skincare
Longevity Technology - 14-Nov-2024A science-backed approach to healthier, younger-looking skin
Genesis partners with NVIDIA to boost AI for designing drugs
Longevity Technology - 13-Nov-2024NVIDIA will support Genesis in optimizing neural networks for 3D data handling
23andMe restructures, cuts 40% of workforce amid financial struggles
BBC - 12-Nov-2024Seven board members recently resigned after a failed buyout offer
Open Bionics has secured £600,000 in funding funding for accessible prosthetics
Norwegian University of Science and Technology (NTNU) - 12-Nov-2024Through the NHS, Open Bionics provides its prosthetics to eligible patients across the UK
Crypto millionaire funds cutting-edge brain research and longevity science
Bloomberg - 11-Nov-2024Projects include Alzheimer’s research, brain implants, and digital brain modeling for safer AI
Atlas Biomed suddenly stopped operations without explanation
BBC - 09-Nov-2024Experts highlight the risks involved in trusting private companies with genetic data
New non-profit funds neuroscience and biology health research
Longevity Technology - 08-Nov-2024Initiatives like The Human Phenotype project aim to improve disease diagnostics and predictions
DNA-testing firm 23andMe faces stock drop, privacy challenges
BBC - 03-Nov-2024Experts highlight privacy risks for families and advocate stricter controls on DNA data use
Graphene breakthrough: Inbrain’s next-gen brain implants target neurological disorders
Longevity Technology - 31-Oct-2024New funding powers AI-driven implants to revolutionize neurological care
Abbvie’s $1.4b bet on alzheimer’s biotech Aliada
Longevity Technology - 29-Oct-2024Aliada’s BBB technology aims to transform CNS drug delivery
Aignostics secures $34m to revolutionize AI in pathology
HIT Consultant - 29-Oct-2024New funding accelerates AI advancements for precision medicine
ADx NeuroSciences partners with Alamar Biosciences to advance neurodegenerative assays
Biospace - 28-Oct-2024Together, they aim to provide pharmaceutical companies with precise tools for drug development
Dyno partners with Roche to enhance gene therapy for brain diseases
Longevity Technology - 25-Oct-2024They aim to use AI-driven capsid design for delivery for complex treatments
Orthocell raises $17m to fast-track nerve repair device launch in the U.S.
Proactive Investor UK - 25-Oct-2024Funding speeds U.S. entry and scales production as Orthocell advances global expansion
Racing against time: the quest to accurately measure ageing
Science - 22-Oct-2024A competition tests top biological clocks to find the best health predictors
Terray raised $120 million to advance AI-driven drug discovery
Longevity Technology - 21-Oct-2024Their partnership with Calico focuses on age-related disease treatments
Horizon Surgical raises $30M to enhance robotic cataract surgery
FierceBiotech - 21-Oct-2024Their Polaris system aims to improve cataract removal precision and consistency
Sunbird Bio secured $14M to advance its Alzheimer’s blood test
Longevity Technology - 18-Oct-2024Clinical study showed its accuracy, aiming to replace invasive methods like PET scans
Tolerance bio raises $17.2M for thymus-based immune disease treatments
Longevity Technology - 16-Oct-2024They use stem cell technology to regenerate the thymus and aim to slow its natural decline
Shift Bioscience raised $16 million to further its AI-driven platform
Longevity Technology - 15-Oct-2024Shift aims to treat diseases like heart issues and arthritis by addressing aging’s root causes
Display all news
